Long-term follow-up (four years) of unprotected left main coronary artery disease treated with paclitaxel-eluting stents (from the TRUE Registry)

EuroIntervention

Volumn 5, Issue 8, 2010, Pages 906-916

  Godino, Cosmo ^a,b   Parodi, Guido ^c   Furuichi, Shinichi ^a   Latib, Azeem ^a   Barbagallo, Rossella ^d   Goktekin, Omer ^f   Cera, Michela ^a   Mueller, Ralf ^e   Tamburino, Corrado ^d   Grube, Eberhard ^e   Di Mario, Carlo ^f   Reimers, Bernard ^g   Chieffo, Alaide ^a   Antoniucci, David ^c   Colombo, Antonio ^a,b   Sangiorgi, Giuseppe M ^h  

^a San Raf faele Institute   (Italy)

^b EMO GVM CENTRO CUORE COLUMBUS   (Italy)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

^d Ferrarotto Hospital   (Italy)

^e Heart Center Siegburg   (Germany)

^f ROYAL BROMPTON HOSPITAL   (United Kingdom)

^g Mirano Hospital   (Italy)

^h UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Coronary arteries; Coronary stenosis; Revascularisation; Stents

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PACLITAXEL; TICLOPIDINE; CARDIOVASCULAR AGENT;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; LEFT CORONARY ARTERY; LOADING DRUG DOSE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; STENT THROMBOSIS; SURGICAL TECHNIQUE; SURVIVAL RATE; THROMBOSIS; TREATMENT DURATION; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; DISEASE FREE SURVIVAL; EUROPE; HEART INFARCTION; HOSPITALIZATION; INSTRUMENTATION; KAPLAN MEIER METHOD; MIDDLE AGED; MULTICENTER STUDY; PROSTHESIS; RADIOGRAPHY; REGISTER; RESTENOSIS; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR AGENTS; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DISEASE-FREE SURVIVAL; DRUG-ELUTING STENTS; EUROPE; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; KAPLAN-MEIERS ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PACLITAXEL; PROSTHESIS DESIGN; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77957059161     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV5I8A154     Document Type: Article

References (35)

1. Chieffo A, Stankovic G, Bonizzoni E, Tsagalou E, Iakovou I, Montorfano M, Airoldi F, Michev I, Sangiorgi MG, Carlino M. Early and Mid-Term Results of Drug-Eluting Stent Implantation in Unprotected Left Main. Circulation. 2005;111:791-795. (Pubitemid 40250640)
2. Park SJ, Kim YH, Lee BK, Lee SW, Lee CW, Hong MK, Kim JJ, Mintz GS, Park SW. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis Comparison with bare metal stent implantation. J Am Coll Cardiol. 2005;45:351-356. (Pubitemid 40186783)
3. Valgimigli M, van Mieghem CAG, Ong ATL, Aoki J, Granillo GAR, McFadden EP, Kappetein AP, de Feyter PJ, Smits PC, Regar E, Van der Giessen WJ, Sianos G, de Jaegere P, Van Domburg RT, Serruys PW. Short- and Long-Term Clinical Outcome After Drug-Eluting Stent Implantation for the Percutaneous Treatment of Left Main Coronary Artery Disease: Insights From the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital Registries (RESEARCH and T-SEARCH). Circulation. 2005;111:1383-1389. (Pubitemid 40396804)
4. Valgimigli M, Malagutti P, Aoki J, Garcia-Garcia HM, Rodriguez Granillo GA, van Mieghem CAG, Ligthart JM, Ong ATL, Sianos G, Regar E. Sirolimus-Eluting Versus Paclitaxel-Eluting Stent Implantation for the Percutaneous Treatment of Left Main Coronary Artery Disease A Combined RESEARCH and T-SEARCH Long-Term Analysis. J Am Coll Cardiol. 2006;47:507-514. (Pubitemid 43170837)
5. Sheiban I, Meliga E, Moretti C, Biondi-Zoccai GGL, Rosano G, Sciuto F, Marra WG, Omedè P, Gerasimou A, Trevi GP. Long-Term Clinical and Angiographic Outcomes of Treatment of Unprotected Left Main Coronary Artery Stenosis With Sirolimus-Eluting Stents. Am J Cardiol. 2007;100:431-435. (Pubitemid 47094692)
6. Meliga E, Garcia-Garcia HM, Valgimigli M, Chieffo A, Biondi-Zoccai G, Maree AO, Cook S, Reardon L, Moretti C, De Servi S. Longest Available Clinical Outcomes After Drug-Eluting Stent Implantation for Unprotected Left Main Coronary Artery Disease: The DELFT (Drug Eluting stent for LeFT main) Registry. J Am Coll Cardiol. 2008;51:2212-9. (Pubitemid 351754998)
7. Chieffo A, Park SJ, Meliga E, Sheiban I, Lee MS, Latib A, Kim YH, Valgimigli M, Sillano D, Magni V. Late and very late stent thrombosis following drug-eluting stent implantation in unprotected left main coronary artery: a multicentre registry. Eur Heart J. 2008;[Epub ahead of print].
8. Price MJ, Cristea E, Sawhney N, Kao JA, Moses JW, Leon MB, Costa RA, Lansky AJ, Teirstein PS. Serial Angiographic Follow-Up of Sirolimus-Eluting Stents for Unprotected Left Main Coronary Artery Revascularization. J Am Coll Cardiol. 2006;47:871-877. (Pubitemid 43243114)
9. Biondi-Zoccai GGL, Sangiorgi GM, Antoniucci D, Grube E, Di Mario C, Reimers B, Tamburino C, Agostoni P, Cosgrave J, Colombo A. Testing prospectively the effectiveness and safety of paclitaxel-eluting stents in over 1000 very high-risk patients: Design, baseline characteristics, procedural data and in-hospital outcomes of the multicenter Taxus in Real-life Usage Evaluation (TRUE) Study. Int J Cardiol. 2007;117:349-354. (Pubitemid 46509806)
10. Smith Jr SC, Feldman TE, Hirshfeld Jr JW, Jacobs AK, Kern MJ, King Iii SB, Morrison DA, O'Neill WW, Schaff HV, Whitlow PL. ACC/AHA/SCAI Practice Guideline. Circulation. 2006;113:156-175.
11. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Gabriel Steg P, Morel M, Mauri L, Vranckx P. Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions. Circulation. 2007;115:2344-51. (Pubitemid 46685903)
12. Parsonnet V, Dean D, Bernstein AD. A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. Circulation. 1989;79:I3-12.
13. Nashef SAM, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardio-Thoracic Surg. 1999;16:9-13. (Pubitemid 29336425)
14. Medina A, Suarez de Lezo J, Pan M. [A new classification of coronary bifurcation lesions]. Rev Esp Cardiol. 2006;59:183.
15. Shammas NW. Trifurcating coronary artery disease: A proposed classification and treatment methodology. J Invasive Cardiol. 2007;19:32.
16. Louvard Y, Thomas M, Dzavik V, Hildick-Smith D, Galassi AR, Pan M, Burzotta F, Zelizko M, Dudek D, Ludman P. Classification of coronary artery bifurcation lesions and treatments: Time for a consensus! Catheter Cardiovasc Interv. 2008;71.
17. Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF, Pichard AD, Kent KM, Stone GW, Leon MB. Angiographic Patterns of In-Stent Restenosis Classification and Implications for Long-Term Outcome. Circulation. 1999;100:1872-1878. (Pubitemid 29511140)
18. Eagle KA, Berger PB, Calkins H. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-executive summary. J Am Coll Cardiol. 2002;39:542-553.
19. d'Allonnes FR, Corbineau H, Le Breton H, Leclercq C, Leguerrier A, Daubert C. Isolated left main coronary artery stenosis: long term follow up in 106 patients after surgery. Heart. 2002;87:544-548.
20. Caracciolo EA, Davis KB, Sopko G, Kaiser GC, Corley SD, Schaff H, Taylor HA, Chaitman BR. Comparison of Surgical and Medical Group Survival in Patients With Left Main Equivalent Coronary Artery Disease : Long-term CASS Experience. Circulation. 1995;91:2335-2344.
21. Serruys PW, Morice M-C, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Stahle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW, the SI. Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease. N Engl J Med. 2009;360:961-972.
22. Chieffo A, Morici N, Maisano F, Bonizzoni E, Cosgrave J, Montorfano M, Airoldi F, Carlino M, Michev I, Melzi G. Percutaneous Treatment With Drug-Eluting Stent Implantation Versus Bypass Surgery for Unprotected Left Main Stenosis: A Single-Center Experience. Circulation. 2006;113:2542-7. (Pubitemid 43948033)
23. Chieffo A, Park SJ, Valgimigli M, Kim YH, Daemen J, Sheiban I, Truffa A, Montorfano M, Airoldi F, Sangiorgi G, Carlino M, Michev I, Lee CW, Hong MK, Park SW, Moretti C, Bonizzoni E, Rogacka R, Serruys PW, Colombo A. Favorable Long-Term Outcome After Drug-Eluting Stent Implantation in Nonbifurcation Lesions That Involve Unprotected Left Main Coronary Artery: A Multicenter Registry. Circulation. 2007;116:158-162. (Pubitemid 47057521)
24. Lee MS, Kapoor N, Jamal F, Czer L, Aragon J, Forrester J, Kar S, Dohad S, Kass R, Eigler N. Comparison of Coronary Artery Bypass Surgery With Percutaneous Coronary Intervention With Drug-Eluting Stents for Unprotected Left Main Coronary Artery Disease. J Am Coll Cardiol. 2006;47:864-870. (Pubitemid 43243113)
25. Palmerini T, Barlocco F, Santarelli A, Bacchi-Reggiani L, Savini C, Baldini E, Alessi L, Ruffini M, Di Credico G, Piovaccari G. A comparison between coronary artery bypass grafting surgery and drug eluting stent for the treatment of unprotected left main coronary artery disease in elderly patients (aged>= 75 years). Eur Heart J. 2007;28:2714-9. (Pubitemid 350135533)
26. Wood FO, Saylors EK, Schneider JE, Jobe RL, Mann 3rd JT. Unprotected left main disease managed with drug-eluting stents: long-term outcome of 100 patients with increased surgical risk. Catheter Cardiovasc Interv. 2008;71:533-8. (Pubitemid 351498100)
27. Biondi-Zoccai GGL, Lotrionte M, Moretti C, Meliga E, Agostoni P, Valgimigli M, Migliorini A, Antoniucci D, Carrié D, Sangiorgi G. A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease. Am Heart Journal. 2008;155:274-283.
28. Pan M, de Lezo JS, Medina A, Romero M, Segura J, Pavlovic D, Delgado A, Ojeda S, Melián F, Herrador J. Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: A randomized comparison of a simple versus complex strategy. Am Heart Journal. 2004;148:857-864.
29. Colombo A, Moses JW, Morice MC, Ludwig J, Holmes DR, Jr., Spanos V, Louvard Y, Desmedt B, Di Mario C, Leon MB. Randomized Study to Evaluate Sirolimus-Eluting Stents Implanted at Coronary Bifurcation Lesions. Circulation. 2004;109:1244-1249. (Pubitemid 38372783)
30. Tanabe K, Hoye A, Lemos PA, Aoki J, Arampatzis CA, Saia F, Lee C, Degertekin M, Hofma SH, Sianos G. Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings. Am J Cardiol. 2004;94:115-118. (Pubitemid 38813465)
31. Hoye A, Iakovou I, Ge L, van Mieghem CAG, Ong ATL, Cosgrave J, Sangiorgi GM, Airoldi F, Montorfano M, Michev I. Long-Term Outcomes After Stenting of Bifurcation Lesions With the "Crush" Technique Predictors of an Adverse Outcome. J Am Coll Cardiol. 2006;47:1949-1958.
32. Park SJ, Hong MK, Lee CW, Kim JJ, Song JK, Kang DH, Park SW, Mintz GS. Elective stenting of unprotected left main coronary artery stenosis Effect of debulking before stenting and intravascular ultrasound guidance. J Am Coll Cardiol. 2001;38:1054-1060. (Pubitemid 32912711)
33. Seung KB, Kim YH, Park DW, Lee BK, Lee CW, Hong MK, Kim PJ, Chung WS, Tahk SJ, Park SW. Effectiveness of Sirolimus-Eluting Stent Implantation for the Treatment of Ostial Left Anterior Descending Artery Stenosis With Intravascular Ultrasound Guidance. J Am Coll Cardiol. 2005;46:787-792. (Pubitemid 41224800)
34. Sano K, Mintz GS, Carlier SG, de Ribamar Costa J, Qian J, Missel E, Shan S, Franklin-Bond T, Boland P, Weisz G. Assessing intermediate left main coronary lesions using intravascular ultrasound. Am Heart Journal. 2007;154:983-988. (Pubitemid 47632490)
35. Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, van den Brand M, Van Dyck N, Russell ME, Mohr F. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005;1:219-227.